We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DLO:NASDAQDLocal Limited Analysis

Data as of 2026-03-29 - not real-time

$12.27

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

DLocal’s share price of $12.27 sits below its 20‑day (12.05), 50‑day (12.77) and 200‑day (13.12) moving averages, signaling a short‑term bearish bias. Yet the MACD histogram has turned positive, volume is increasing, and the RSI hovers around 49, hinting at a possible near‑term reversal. The stock trades at a trailing P/E of 18.9 and forward P/E of 11.3—well under the industry average of 32—while a discounted cash‑flow model estimates a fair value of $43.6, implying roughly 44% upside. Revenue surged 65% YoY to $1.09 bn, TPV jumped 70% YoY, and operating margins sit near 19%, reflecting high growth. A strong balance sheet ($843 m cash vs $90 m debt) and a 0% payout ratio sustain the 1.58% dividend, making the payout sustainable. The market cap of $3.6 bn and an average 10‑day volume of 2.2 m shares provide decent liquidity. The beta of 1.23 suggests the stock moves more than the market, amplifying both upside and downside.
Nevertheless, volatility is elevated at 56% over the past 30 days and beta of 1.23 indicate pronounced price swings, while exposure to emerging‑market regulators raises medium‑high geographic and regulatory risk. The company’s ROE of 37% and a track record of beating earnings estimates have spurred bullish commentary and a recent 9% rally to $12.53. The current support at $11.16 and resistance near $13.5 give a clear technical range for traders. While the max drawdown of 28% over recent periods underscores downside risk, the upside potential remains compelling. Overall sentiment on the Fear & Greed Index is in "Greed" territory (65.98), reflecting bullish market mood toward the stock.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive MACD histogram and rising volume
  • Technical support at $11.16 offering downside cushion
  • Valuation discount to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 65% YoY revenue growth
  • Strong cash generation and low debt
  • Forward P/E of 11.3 indicating cheapness

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustained high ROE (37%)
  • Expanding TPV in emerging markets
  • Robust balance sheet with ample cash

Key Metrics & Analysis

Financial Health

Revenue Growth65.20%
Profit Margin18.00%
P/E Ratio18.9
ROE37.21%
ROA10.13%
Debt/Equity15.86
P/B Ratio6.4
Op. Cash Flow$415.5M
Free Cash Flow$332.3M
Industry P/E32.0

Technical Analysis

TrendBearish
RSI49.0
Support$11.16
Resistance$13.50
MA 20$12.05
MA 50$12.77
MA 200$13.12
MACDBullish
VolumeIncreasing
Fear & Greed Index65.98

Valuation

Fair Value$43.58
Target Price$17.75
Upside/Downside44.66%
GradeUndervalued
TypeGrowth
Dividend Yield1.58%

Risk Assessment

Beta1.24
Volatility56.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.